[
  {
    "ts": null,
    "headline": "BAX Q3 Deep Dive: Mixed Segment Results and Lowered Guidance Drive Market Reaction",
    "summary": "Healthcare company Baxter International (NYSE:BAX) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5% year on year to $2.84 billion. Next quarter’s revenue guidance of $2.81 billion underwhelmed, coming in 6.5% below analysts’ estimates. Its non-GAAP profit of $0.69 per share was 15.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=18e0a038115d336d5544588c4c06d80519cdf9e43836b08afc8b86a67a110db3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761920486,
      "headline": "BAX Q3 Deep Dive: Mixed Segment Results and Lowered Guidance Drive Market Reaction",
      "id": 137279745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BAX",
      "source": "Yahoo",
      "summary": "Healthcare company Baxter International (NYSE:BAX) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 5% year on year to $2.84 billion. Next quarter’s revenue guidance of $2.81 billion underwhelmed, coming in 6.5% below analysts’ estimates. Its non-GAAP profit of $0.69 per share was 15.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=18e0a038115d336d5544588c4c06d80519cdf9e43836b08afc8b86a67a110db3"
    }
  }
]